Inborn errors of metabolism causing epilepsy

Shamima Rahman1, Emma J Footitt, Sophia Varadkar

  • 1Clinical and Molecular Genetics and Neurosciences Units, University College London Institute of Child Health, London and Metabolic and Neurosciences Units, Great Ormond Street Hospital for Children NHS Trust, London, UK. shamima.rahman@ucl.ac.uk

Insights

Seizures can signal inborn errors of metabolism (IEMs), especially in newborns. This review guides diagnosis and treatment for IEMs presenting with seizures, focusing on conditions with available therapies.

Area of Science:

  • Metabolic disorders
  • Neurology
  • Pediatrics

Background:

  • Seizures are a primary symptom in some inborn errors of metabolism (IEMs).
  • Other IEMs manifest with seizures after initial symptoms like reduced consciousness or developmental regression.
  • This review focuses on IEMs with available specific treatments.

Purpose of the Study:

  • To review inborn errors of metabolism (IEMs) that present with seizures.
  • To correlate age at presentation with common metabolic causes of seizures.
  • To guide diagnosis of IEMs with specific treatments.

Main Methods:

  • Literature review of IEMs presenting with seizures.
  • Analysis of clinical features, imaging, and biochemical investigations.
  • Focus on disorders with established therapeutic interventions.

Main Results:

  • Metabolic causes of seizures vary significantly with patient age.
  • Clinical history, examination, imaging, and initial biochemical tests offer diagnostic clues.
  • Specific diagnostic tests are crucial for identifying treatable IEMs.

Conclusions:

  • Early recognition of seizures as a symptom of IEM is critical.
  • A systematic approach integrating clinical and biochemical data aids diagnosis.
  • Prompt diagnosis enables timely initiation of specific treatments for better outcomes.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...